2022年12月最新中科院JCR期刊分区表数据（升级版）已经更新，欢迎查询！ 如果您对期刊系统有任何需求或者问题，欢迎反馈给我们。
 |
| 基本信息 | 登录收藏 | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | INTERNATIONAL IMMUNOPHARMACOLOGY INT IMMUNOPHARMACOL LetPub评分 6.9
58人评分
我要评分
声誉 7.7 影响力 5.8 速度 9.3 | |||||||||||||||||||||||||
| 期刊ISSN | 1567-5769 | 微信扫码收藏此期刊 | ||||||||||||||||||||||||
| E-ISSN | 1878-1705 | |||||||||||||||||||||||||
| 2021-2022最新影响因子 （数据来源于搜索引擎） | 注册或登录后，查看影响因子和历年趋势图 | |||||||||||||||||||||||||
| 2021-2022自引率 | 4.40%注册或登录后，查看自引率趋势图 | |||||||||||||||||||||||||
| h-index | 98 | |||||||||||||||||||||||||
| CiteScore |
| |||||||||||||||||||||||||
| 期刊简介 | International Immunopharmacology is the primary vehicle for the publication of original research papers pertinent to the overlapping areas of immunology, pharmacology, cytokine biology, immunotherapy, immunopathology and immunotoxicology. Review articles that encompass these subjects are also welcome. The subject material appropriate for submission includes: • Clinical studies employing immunotherapy of any type including the use of: bacterial and chemical agents; thymic hormones, interferon, lymphokines, etc., in transplantation and diseases such as cancer, immunodeficiency, chronic infection and allergic, inflammatory or autoimmune disorders. • Studies on the mechanisms of action of these agents for specific parameters of immune competence as well as the overall clinical state. • Pre-clinical animal studies and in vitro studies on mechanisms of action with immunopotentiators, immunomodulators, immunoadjuvants and other pharmacological agents active on cells participating in immune or allergic responses. • Pharmacological compounds, microbial products and toxicological agents that affect the lymphoid system, and their mechanisms of action. • Agents that activate genes or modify transcription and translation within the immune response. • Substances activated, generated, or released through immunologic or related pathways that are pharmacologically active. • Production, function and regulation of cytokines and their receptors. • Classical pharmacological studies on the effects of chemokines and bioactive factors released during immunological reactions. | |||||||||||||||||||||||||
| 期刊官方网站 | http://www.elsevier.com/wps/find/journaldescription.cws_home/621330/description#description | |||||||||||||||||||||||||
| 期刊投稿网址 | https://www.editorialmanager.com/INTIMP | |||||||||||||||||||||||||
| 是否OA开放访问 | No | |||||||||||||||||||||||||
| 通讯方式 | ELSEVIER SCIENCE BV, PO BOX 211, AMSTERDAM, NETHERLANDS, 1000 AE | |||||||||||||||||||||||||
| 出版商 | Elsevier | |||||||||||||||||||||||||
| 涉及的研究方向 | 医学-免疫学 | |||||||||||||||||||||||||
| 出版国家或地区 | NETHERLANDS | |||||||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||||||
| 出版周期 | Monthly | |||||||||||||||||||||||||
| 出版年份 | 2001 | |||||||||||||||||||||||||
| 年文章数 | 1023注册或登录后，查看年文章数趋势图 | |||||||||||||||||||||||||
| Gold OA文章占比 | 7.25% | |||||||||||||||||||||||||
| 研究类文章占比： 文章 ÷（文章 + 综述） | 88.27% | |||||||||||||||||||||||||
| WOS期刊SCI分区 （ 2021-2022年最新版） | WOS分区等级：1区
| |||||||||||||||||||||||||
| 中科院《国际期刊预警 名单（试行）》名单 | 2021年12月发布的2021版：不在预警名单中 2021年01月发布的2020版：不在预警名单中 | |||||||||||||||||||||||||
| 中科院SCI期刊分区 （ 2022年12月最新升级版） | 注册或登录后，查看中科院SCI期刊分区趋势图
| |||||||||||||||||||||||||
| 中科院SCI期刊分区 （ 2021年12月基础版） |
| |||||||||||||||||||||||||
| 中科院SCI期刊分区 （ 2021年12月升级版） |
| |||||||||||||||||||||||||
| 中科院SCI期刊分区 （ 2020年12月旧的升级版） |
| |||||||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE) Scopus (CiteScore) | |||||||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1567-5769%5BISSN%5D | |||||||||||||||||||||||||
| 平均审稿速度 | 网友分享经验： 平均2.7个月 来源Elsevier官网： 平均7.5周 | |||||||||||||||||||||||||
| 平均录用比例 | 网友分享经验： 约81.66% | |||||||||||||||||||||||||
| 在线出版周期 | 来源Elsevier官网： 平均2.7周 | |||||||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||||||
|
|
| |
| 注册或登录后，查看自引率趋势图 |
| 注册或登录后，查看中科院SCI期刊分区趋势图 |
| 注册或登录后，查看年文章数趋势图 |
| 中国学者近期发表的论文 | |
| 1. | Protective effects of berberine hydrochloride on DSS-induced ulcerative colitis in rats Author: Lei Zhu, PeiQing Gu, Hong Shen Journal: INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, Vol.68, 242-251, DOI:10.1016/j.intimp.2018.12.036 DOI |
| 2. | Extracellular vesicles containing miR-146a attenuate experimental colitis by targeting TRAF6 and IRAK1 Author: Hui Wu, Heng Fan, Zhexing Shou, Meng Xu, Qianyun Chen, Changzheng Ai, Yalan Dong, Yujin Liu, Zhen Nan, Yifan Wang, Ting Yu, Xingxing Liu Journal: INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, Vol.68, 204-212, DOI:10.1016/j.intimp.2018.12.043 DOI |
| 3. | Protective effects of alogliptin against TNF-α-induced degradation of extracellular matrix in human chondrocytes Author: Panpan Zhang, Yuhua Chen, Huafei Zhao, Hao Du Journal: INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, Vol.68, 179-184, DOI:10.1016/j.intimp.2018.11.007 DOI |
| 4. | Glycyrrhizin attenuates hepatic ischemia-reperfusion injury by suppressing HMGB1-dependent GSDMD-mediated kupffer cells pyroptosis Author: Shuyao Hua, Mingyang Ma, Xiaoyuan Fei, Yuanyue Zhang, Feili Gong, Min Fang Journal: INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, Vol.68, 145-155, DOI:10.1016/j.intimp.2019.01.002 DOI |
| 5. | Vitamin D alleviates airway remodeling in asthma by down-regulating the activity of Wnt/β-catenin signaling pathway Author: Yue Huang, Lei Wang, Xiao-xiao Jia, Xi-xi Lin, Wei-xi Zhang Journal: INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, Vol.68, 88-94, DOI:10.1016/j.intimp.2018.12.061 DOI |
| 6. | Salidroside protects ATDC5 cells against lipopolysaccharide-induced injury through up-regulation of microRNA-145 in osteoarthritis Author: Meihan Liu, Jingzhe Zhang, Wanguo Liu, Wenjun Wang Journal: INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, Vol.67, 441-448, DOI:10.1016/j.intimp.2018.12.041 DOI |
| 7. | Adiponectin alleviates exacerbation of airway inflammation and oxidative stress in obesity-related asthma mice partly through AMPK signaling pathway Author: Lili Zhu, Xiuzhen Chen, Lei Chong, Ludan Kong, Shunhang Wen, Hailin Zhang, Weixi Zhang, Changchong Li Journal: INTERNATIONAL IMMUNOPHARMACOLOGY, 2018, Vol.67, 396-407, DOI:10.1016/j.intimp.2018.12.030 DOI |
| 8. | Evaluation of PD-L1 biomarker for immune checkpoint inhibitor (PD-1/PD-L1 inhibitors) treatments for urothelial carcinoma patients: A meta-analysis Author: Xin Rui, Ting-Ting Gu, Hua-Feng Pan, Hui-Zhi Zhang Journal: INTERNATIONAL IMMUNOPHARMACOLOGY, 2018, Vol.67, 378-385, DOI:10.1016/j.intimp.2018.12.018 DOI |
| 9. | Short-term use of MyD88 inhibitor TJ-M2010-5 prevents d-galactosamine/lipopolysaccharide-induced acute liver injury in mice Author: Zuochuan Ding, Dunfeng Du, Yang Yang, Min Yang, Yan Miao, Zhimiao Zou, Xiaoqian Zhang, Zeyang Li, Xue Zhang, Limin Zhang, Xinqiang Wang, Yuanyuan Zhao, Jipin Jiang, Fengchao Jiang, Ping Zhou Journal: INTERNATIONAL IMMUNOPHARMACOLOGY, 2018, Vol.67, 356-365, DOI:10.1016/j.intimp.2018.11.051 DOI |
| 10. | SIRT1 alleviates isoniazid-induced hepatocyte injury by reducing histone acetylation in the IL-6 promoter region Author: Yiyang Zhang, Yingshu Li, Jinfeng Li, Biao Li, Yingzhi Chong, Guoying Zheng, Shufeng Sun, Fumin Feng Journal: INTERNATIONAL IMMUNOPHARMACOLOGY, 2018, Vol.67, 348-355, DOI:10.1016/j.intimp.2018.11.054 DOI |
|
|
  | |
|
以上SCI期刊相关数据和信息来源于网络，仅供参考。
投稿状态统计： 我要评分： | |
同领域作者分享投稿经验：共19条 （包含回复） |
我来分享 |
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2023 中国: LetPub上海分公司 网站备案号：沪ICP备10217908号-1 
沪公网安备号：31010402006960
增值电信业务经营许可证：沪B2-20211595
礼翰商务信息咨询（上海）有限公司 办公地址：上海市徐汇区漕溪北路88号圣爱大厦2103室
United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451
安全保密
